Kinetic Group 

$2
2
+$0+0% Thursday 21:00

Statistics

Day High
2
Day Low
1.71
52W High
5
52W Low
1.71
Volume
200
Avg. Volume
0
Mkt Cap
52.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q2 2020
-0.01
-0
0
0.01
Expected EPS
0
Actual EPS
0.0075

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-190,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KNIT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Adaptive Biotechnologies
ADPT
Mkt Cap2.64B
Adaptive Biotechnologies offers similar immune-driven healthcare solutions, competing directly in the biotech sector.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomic sequencing solutions that overlap with Kinetic's biotechnological applications.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a field closely related to Kinetic's work in genetic research and manipulation.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics also specializes in CRISPR technology, making it a direct competitor in the gene-editing space.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine operates in the genome editing industry, competing in the same niche as Kinetic.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals works on biotechnological treatments that can be seen as alternatives to Kinetic's offerings.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals engages in creating drug therapies that could compete with Kinetic's biotech solutions.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals focuses on RNAi therapeutics, which are part of the broader biotech field where Kinetic operates.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical offers therapies for rare genetic diseases, potentially competing with Kinetic's patient-specific treatments.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics focuses on genomic medicine, directly competing with Kinetic in gene therapy and editing technologies.

About

Kinetic Group Inc., a telecommunications company, focuses on owning, operating, and building wireless infrastructure for mobile carriers in Latin America. The company rents, operates, and builds tower/rooftop/unconventional infrastructure, fiber optic networks, DAS, and telecommunication equipment for MNO's. Kinetic Group Inc. was incorporated in 2014 and is based in Miami Florida.
Show more...
CEO
Ms. Ana Maria Mendez
Employees
2
Country
US
ISIN
US4946122037

Listings

0 Comments

Share your thoughts

FAQ

What is Kinetic Group stock price today?
The current price of KNIT is $2 USD — it has increased by +0% in the past 24 hours. Watch Kinetic Group stock price performance more closely on the chart.
What is Kinetic Group stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kinetic Group stocks are traded under the ticker KNIT.
What is Kinetic Group market cap?
Today Kinetic Group has the market capitalization of 52.84M
What were Kinetic Group earnings last quarter?
KNIT earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kinetic Group revenue for the last year?
Kinetic Group revenue for the last year amounts to 0 USD.
What is Kinetic Group net income for the last year?
KNIT net income for the last year is -190,000 USD.
How many employees does Kinetic Group have?
As of April 04, 2026, the company has 2 employees.
In which sector is Kinetic Group located?
Kinetic Group operates in the Communication Services sector.
When did Kinetic Group complete a stock split?
Kinetic Group has not had any recent stock splits.
Where is Kinetic Group headquartered?
Kinetic Group is headquartered in Miami, US.